The document discusses vaccine delivery systems. It begins by introducing vaccines and how they work, preparing the immune system to recognize and fight pathogens. It then discusses different types of vaccines and delivery methods, including live attenuated, inactivated, toxoid, conjugate, and subunit vaccines. Physical approaches like electroporation and chemical/vesicular approaches like liposomes, niosomes, and viral vectors can be used for transdermal vaccine delivery to stimulate an immune response. The skin is a promising target for topical vaccination due to immune cells present that can recognize antigens and initiate a response.
Vaccines work by enhancing the body's immune response to disease-causing microorganisms. They contain weakened or killed forms of viruses or bacteria, or purified components, which trigger an immune response and develop antibodies without causing illness. Vaccines are formulated with antigens, fluids, preservatives and adjuvants to ensure potency over the shelf life. They are prepared from isolated microbial strains grown in culture and tested in clinical trials before use in vaccine production. The immune response triggered by vaccination mimics natural infection and prepares the body to fight the disease if exposed in the future.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize foreign agents, destroy it, and keep a record of it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
This document discusses single shot vaccines that can provide protection against multiple diseases with only one injection. It describes how single shot vaccines work by combining an antigen, adjuvant, and microsphere component that encapsulates and slowly releases the antigen. Key factors in developing these vaccines include controlling particle size, optimizing encapsulation efficiency, and regulating antigen release from the biodegradable microspheres. Single shot vaccines offer advantages like improved patient compliance and lower costs compared to traditional multi-dose vaccines.
This document discusses vaccine drug delivery systems. It begins with an introduction to vaccines, including their history and mechanisms of action. It then covers various types of vaccines such as live attenuated, inactivated, subunit, toxoid, recombinant protein, and RNA vaccines. The document discusses antigen uptake pathways and the mechanisms by which endogenous and exogenous antigens are processed. It also covers topics like single shot vaccines, mucosal delivery systems, transdermal delivery systems, adjuvants, and advanced encapsulation methods for vaccine development.
Contents
IntroductionWhat are vaccine?
History of vaccineIdeal properties of vaccine.
Mechanism of vaccine
Types of vaccineUptake of antigen
Single shot vaccine
Mucosal delivery vaccine
Transdermal delivery vaccineReferences
Vaccine delivery systems can be categorized as needle-based or needle-free. Common needle-based routes include intramuscular, subcutaneous, and intradermal injection. Needle-free options include oral, intranasal, and transdermal delivery. Various technologies are being developed to enhance vaccine uptake through mucosal surfaces without needles, such as live viral/bacterial vectors, particulate systems like microparticles, and chemical or physical permeation of the skin. The design of mucosal and transdermal vaccines aims to protect antigens, deliver them across barriers, and target immune cells while avoiding tolerance.
This document provides an overview of vaccine delivery systems. It discusses various types of delivery systems including particulate adjuvants like aluminum salts, virosomes, and cytokines. It also describes mucosal vaccine delivery systems and strategies for mucosal delivery including emulsion-type delivery, liposome-based delivery, and polymeric nano particles. The key advantages and disadvantages of different delivery approaches are highlighted.
The document discusses single-shot vaccines and their delivery systems. It defines vaccines and describes traditional types including killed, attenuated, and subunit. It explains antigen uptake, processing, and presentation by cells. Microsphere-based single-shot vaccines provide priming and boosting through delayed antigen release. Factors influencing release include polymer properties and antigen size. Future areas of research include combining pulsatile delivery with existing vaccines to mimic multiple doses through a single injection. Adverse effects are usually mild and include fever and pain, while risks involve potential illness from live vaccines or allergic reactions.
Vaccines work by enhancing the body's immune response to disease-causing microorganisms. They contain weakened or killed forms of viruses or bacteria, or purified components, which trigger an immune response and develop antibodies without causing illness. Vaccines are formulated with antigens, fluids, preservatives and adjuvants to ensure potency over the shelf life. They are prepared from isolated microbial strains grown in culture and tested in clinical trials before use in vaccine production. The immune response triggered by vaccination mimics natural infection and prepares the body to fight the disease if exposed in the future.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize foreign agents, destroy it, and keep a record of it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
This document discusses single shot vaccines that can provide protection against multiple diseases with only one injection. It describes how single shot vaccines work by combining an antigen, adjuvant, and microsphere component that encapsulates and slowly releases the antigen. Key factors in developing these vaccines include controlling particle size, optimizing encapsulation efficiency, and regulating antigen release from the biodegradable microspheres. Single shot vaccines offer advantages like improved patient compliance and lower costs compared to traditional multi-dose vaccines.
This document discusses vaccine drug delivery systems. It begins with an introduction to vaccines, including their history and mechanisms of action. It then covers various types of vaccines such as live attenuated, inactivated, subunit, toxoid, recombinant protein, and RNA vaccines. The document discusses antigen uptake pathways and the mechanisms by which endogenous and exogenous antigens are processed. It also covers topics like single shot vaccines, mucosal delivery systems, transdermal delivery systems, adjuvants, and advanced encapsulation methods for vaccine development.
Contents
IntroductionWhat are vaccine?
History of vaccineIdeal properties of vaccine.
Mechanism of vaccine
Types of vaccineUptake of antigen
Single shot vaccine
Mucosal delivery vaccine
Transdermal delivery vaccineReferences
Vaccine delivery systems can be categorized as needle-based or needle-free. Common needle-based routes include intramuscular, subcutaneous, and intradermal injection. Needle-free options include oral, intranasal, and transdermal delivery. Various technologies are being developed to enhance vaccine uptake through mucosal surfaces without needles, such as live viral/bacterial vectors, particulate systems like microparticles, and chemical or physical permeation of the skin. The design of mucosal and transdermal vaccines aims to protect antigens, deliver them across barriers, and target immune cells while avoiding tolerance.
This document provides an overview of vaccine delivery systems. It discusses various types of delivery systems including particulate adjuvants like aluminum salts, virosomes, and cytokines. It also describes mucosal vaccine delivery systems and strategies for mucosal delivery including emulsion-type delivery, liposome-based delivery, and polymeric nano particles. The key advantages and disadvantages of different delivery approaches are highlighted.
The document discusses single-shot vaccines and their delivery systems. It defines vaccines and describes traditional types including killed, attenuated, and subunit. It explains antigen uptake, processing, and presentation by cells. Microsphere-based single-shot vaccines provide priming and boosting through delayed antigen release. Factors influencing release include polymer properties and antigen size. Future areas of research include combining pulsatile delivery with existing vaccines to mimic multiple doses through a single injection. Adverse effects are usually mild and include fever and pain, while risks involve potential illness from live vaccines or allergic reactions.
The document discusses strategies for effective mucosal immunization. It begins by describing the structure and function of the mucosal immune system, which lines various tracts in the body and is the site of entry for many pathogens. It then discusses the challenges of delivering vaccines mucosally, including dilution in fluids and degradation, before outlining approaches to overcome barriers like targeting antigen-presenting cells. The rest of the document details various nanoparticle delivery systems for mucosal vaccines, including liposomes, emulsions, polymeric nanoparticles, virus-like particles, and virosomes. It emphasizes the ability of these systems to protect antigens, penetrate mucosal barriers, and promote immune responses.
Preparation & stability of large & small volume parentralsROHIT
This document discusses parenteral formulations, including definitions, advantages, disadvantages, and classifications. It provides details on the preparation of small volume parenterals and large volume parenterals, including vehicles, buffers, preservatives, and other excipients used. It also covers the stability considerations for parenteral formulations and factors that influence syringeability, injectability, clogging, drainage, resuspendibility, and sedimentation of suspensions.
This document discusses gastrointestinal transit, which is the time it takes for food or drugs to pass through the stomach and intestines. It notes that transit time can vary significantly between individuals and depends on factors like diet, medications, gender, and health conditions. The document then provides details on the anatomy and layers of the GI tract. It describes the functions of different sections like the stomach, small intestine, and large intestine. Transit times through each section are provided. Motility patterns and their influence on GI transit in fasted and fed states are also summarized.
Dr. A. SUMATHI - Transdermal Delivery of VaccinesSumathi Arumugam
The document discusses transdermal delivery of vaccines as a needle-free method of immunization. It describes the skin as a barrier to vaccine delivery and various approaches to overcome these barriers, including needle-free injection devices, powder-based delivery, topical adjuvants, colloidal carriers, and energy-based methods. It provides examples of research demonstrating the ability of these approaches to enhance immune responses to various vaccines compared to traditional needle injection.
This document discusses compaction profiles, which establish the relationship between axial and radial force during tablet punching. It describes three types of compaction profiles: force time profiles, force displacement profiles, and die wall profiles. Force time profiles characterize the compression, dwell, and decompression phases. Force displacement profiles assess material deformation behavior. Die wall force profiles provide information on friction between materials and the die wall. Compaction profiles provide information on a material's compaction behavior and properties that can be used to optimize the tableting process.
DIffusion, Dissolution and Pharmacokinetic Parameters.pptxKailas Mali
This document discusses various parameters used to study drug release and dissolution from pharmaceutical dosage forms, including diffusion parameters, dissolution parameters, pharmacokinetic parameters, and models like Higuchi and Peppas plots. It defines key terms like diffusion, flux, Fick's first law, and discusses how factors like agitation, pH, surfactants, viscosity, and temperature can influence dissolution. Key drug release mechanisms and models are also summarized.
This document discusses personalized medicine and pharmacogenetics. It defines personalized medicine as providing the right drug to the right patient for the right disease at the right time with the right dosage based on an understanding of the patient's genome. Pharmacogenetics is the study of how genetic variations impact individual responses to drugs by influencing drug metabolism and transport. Examples are provided of genetic polymorphisms that can affect drug acetylation, alcohol metabolism, and response to drugs like clopidogrel, antimalarials, and warfarin. While pharmacogenetics enables more precise treatment, limitations include complex interactions between multiple genes, environment, and other drugs.
1. Dissolution is the process by which a solid substance dissolves in a solvent to form a solution. The rate of dissolution depends on factors like temperature, solvent composition, and the liquid/solid interface area.
2. There are several theories that describe the drug dissolution process, including the diffusion layer model, penetration or surface renewal theory, and interfacial barrier model. The most common model is the diffusion layer model, which involves the formation of a saturated film at the solid/liquid interface and diffusion of the drug through this layer.
3. Key factors that affect drug dissolution include the solubility and permeability of the drug substance, the pH and volume of the dissolution medium, and the design of
This document provides information on pulmonary drug delivery systems and aerosols. It discusses the advantages of pulmonary drug delivery such as localized drug deposition reducing systemic exposure and avoidance of first-pass metabolism. Aerosols are defined as colloidal systems containing liquid/solid particles suspended in a propellant. The document outlines the manufacturing process, components, and quality control tests of aerosols including pressure filling, cold filling, and compressed gas filling apparatuses. Evaluation tests like flash point and flame projection are also mentioned.
The document discusses vaccine delivery systems. It describes the types of vaccines including live attenuated, killed, subunit, conjugate, and DNA vaccines. It discusses various delivery routes for vaccines including mucosal, transdermal, and single shot delivery to provide long-lasting immunity from one dose. Strategies for delivery include vectors, microparticles, and liposomes to protect antigens and induce immune responses. The optimal delivery system depends on the disease and vaccine properties.
1) Vaccine delivery systems aim to improve the immune response to vaccines. Virosomes are a type of delivery system that are biodegradable, biocompatible, and non-toxic. They enable drug delivery into target cells and protect drugs from degradation. However, virosomes have short shelf lives and scaling up poses challenges.
2) Vaccines work by exposing the immune system to antigens from pathogens in a way that stimulates antibody production without causing illness. Antibodies bind to antigens and help the immune system recognize and destroy pathogens. Vaccines contain antigens along with other ingredients like adjuvants to enhance the immune response.
3) There are various types of traditional and innovative vaccines that target different
This document discusses mucosal delivery of vaccines. It begins by introducing mucosal surfaces as the major portal of entry for many pathogens and that immunization through mucosal routes can induce protective immunity at sites of entry. It then discusses various terms related to mucosal tissues and lymphoid structures. The remainder of the document outlines different polymer systems, formulations, design strategies and advantages/limitations for mucosal vaccine delivery, including emulsions, liposomes, polymeric nanoparticles, virosomes and melt-in-mouth strips. It also discusses single shot vaccines that provide protection from multiple diseases with one administration through use of vaccine adjuvants and antigen microencapsulation for delayed release.
This document presents theories of dispersion and mechanisms of emulsion formation. It discusses four traditional theories of dispersion: viscosity theory, film theory, wedge theory, and interfacial tension theory. It also describes limitations of these theories. The document then introduces a modern approach involving droplet formation and stabilization by emulsifying agents. Three mechanisms of emulsion stabilization are described: monomolecular adsorption, multimolecular adsorption, and solid particle adsorption.
This document discusses excipients and their role in drug formulations. It notes that excipients are ingredients other than the active pharmaceutical ingredient that are used to formulate dosage forms. Excipients can act as protective agents, bulking agents, and can improve drug bioavailability. The document then lists common types of excipients and potential interactions between drugs and excipients, such as physical, chemical, biopharmaceutical, and excipient-excipient interactions. It describes several analytical techniques used to detect drug-excipient interactions, including DSC, accelerated stability studies, FT-IR, DRS, chromatography methods, and others.
Self micro-emulsifying drug delivery system (SMEDDS)Himal Barakoti
This document discusses self-microemulsifying drug delivery systems (SMEDDS), including their background, mechanism of action, formulations, stability testing, advantages, and applications. SMEDDS are isotropic mixtures of oils, surfactants, and co-surfactants that form fine oil-in-water emulsions upon mild agitation followed by dilution in gastrointestinal fluids. They can improve the oral absorption of poorly water-soluble drugs and enhance their bioavailability. SMEDDS formulations typically contain an oil, surfactant, co-surfactant, and drug. Their small particle size allows efficient drug release in the GI tract. Stability testing evaluates factors like temperature effects and in vitro drug release. SMEDDS
Mr. Swapnil Kale presented on mucosal delivery of vaccines. He discussed that mucosal delivery allows vaccines to interact with mucosal layers to induce mucosal immunity, preventing pathogens from reaching systemic circulation. Common mucosal routes include sublingual, intranasal, oral, vaginal, and rectal. Mucosal delivery provides advantages like priming primary immunity, enabling mass vaccination through needle-free and non-invasive means. However, challenges include insufficient antigen uptake due to rapid clearance and lack of effective human mucosal adjuvants. Nanotechnology approaches can help overcome these challenges by protecting antigens from degradation and facilitating penetration and sustained release with the use of polymers and adjuvants.
1) Tablet compression involves the application of force to reduce the volume of powder materials through three main processes: compression, compaction, and consolidation. Compression removes air, compaction rearranges particles, and consolidation increases strength through bonding.
2) Key forces involved in compression include inter-particulate and die wall friction, which can be reduced by adding glidants and lubricants, respectively. Distribution forces transmit pressure from the punches to the powder bed and die wall.
3) Compaction profiles examine the relationship between axial and radial pressure. They provide information on elastic versus plastic deformation and ejection forces.
This document discusses the differences between sustained release and controlled release drug formulations and their mechanisms of drug delivery. Sustained release aims to slowly release drug over 8-12 hours, while controlled release delivers drug at a predetermined rate according to bodily needs. Mechanisms include dissolution control using matrix or encapsulation methods, diffusion control using reservoir or matrix devices, and combinations of dissolution and diffusion. Common polymers used for coatings include ethyl cellulose and acrylic resins to control drug release rate.
Immunology - Innate and Acquired ImmunityShigina E S
Title: Innate and Acquired Immunity: Understanding the Two Branches of Our Immune System
Introduction:
The human immune system is a complex network of cells, tissues, and organs that protects us from invading pathogens and foreign substances. In this presentation, we will explore the two branches of the immune system: innate and acquired immunity. We will discuss the key features of each branch, their mechanisms of action, and how they work together to keep us healthy.
Section 1: Innate Immunity
- Innate immunity is the first line of defense against pathogens and foreign substances.
- We will discuss the key features of innate immunity, including physical barriers, such as skin and mucous membranes, and the cellular and molecular components of innate immunity, such as phagocytes and cytokines.
- We will also explore some of the ways in which innate immunity can be activated and how it responds to different types of pathogens.
Section 2: Acquired Immunity
- Acquired immunity, also known as adaptive immunity, is a more specialized and targeted response to specific pathogens or foreign substances.
- We will discuss the key features of acquired immunity, including the role of B and T lymphocytes, antibodies, and memory cells.
- We will also explore some of the ways in which acquired immunity can be activated, including through vaccination, and how it responds to specific antigens.
Section 3: Interaction between Innate and Acquired Immunity
- Innate and acquired immunity work together in a coordinated manner to provide effective protection against pathogens and foreign substances.
- We will discuss how innate immunity can initiate an immune response and activate acquired immunity, and how acquired immunity can enhance the effectiveness of innate immunity.
- We will also explore some examples of how these two branches of the immune system work together in different types of infections.
Conclusion:
Understanding the different branches of our immune system is essential for developing effective strategies to prevent and treat infectious diseases. Innate and acquired immunity work together to provide a coordinated and dynamic defense against pathogens and foreign substances. By exploring the mechanisms and interactions between these two branches of the immune system, we can gain a deeper appreciation for the complexity and power of our immune system.
The document discusses the human immune system. It describes how the innate immune system provides an immediate response to pathogens through physical barriers and cells. If pathogens breach these defenses, the adaptive immune system provides a targeted response through B cells and T cells. The adaptive system also develops immunological memory to mount faster responses. Vaccinations work by exposing the immune system to antigens to develop immunity without causing disease.
The document discusses strategies for effective mucosal immunization. It begins by describing the structure and function of the mucosal immune system, which lines various tracts in the body and is the site of entry for many pathogens. It then discusses the challenges of delivering vaccines mucosally, including dilution in fluids and degradation, before outlining approaches to overcome barriers like targeting antigen-presenting cells. The rest of the document details various nanoparticle delivery systems for mucosal vaccines, including liposomes, emulsions, polymeric nanoparticles, virus-like particles, and virosomes. It emphasizes the ability of these systems to protect antigens, penetrate mucosal barriers, and promote immune responses.
Preparation & stability of large & small volume parentralsROHIT
This document discusses parenteral formulations, including definitions, advantages, disadvantages, and classifications. It provides details on the preparation of small volume parenterals and large volume parenterals, including vehicles, buffers, preservatives, and other excipients used. It also covers the stability considerations for parenteral formulations and factors that influence syringeability, injectability, clogging, drainage, resuspendibility, and sedimentation of suspensions.
This document discusses gastrointestinal transit, which is the time it takes for food or drugs to pass through the stomach and intestines. It notes that transit time can vary significantly between individuals and depends on factors like diet, medications, gender, and health conditions. The document then provides details on the anatomy and layers of the GI tract. It describes the functions of different sections like the stomach, small intestine, and large intestine. Transit times through each section are provided. Motility patterns and their influence on GI transit in fasted and fed states are also summarized.
Dr. A. SUMATHI - Transdermal Delivery of VaccinesSumathi Arumugam
The document discusses transdermal delivery of vaccines as a needle-free method of immunization. It describes the skin as a barrier to vaccine delivery and various approaches to overcome these barriers, including needle-free injection devices, powder-based delivery, topical adjuvants, colloidal carriers, and energy-based methods. It provides examples of research demonstrating the ability of these approaches to enhance immune responses to various vaccines compared to traditional needle injection.
This document discusses compaction profiles, which establish the relationship between axial and radial force during tablet punching. It describes three types of compaction profiles: force time profiles, force displacement profiles, and die wall profiles. Force time profiles characterize the compression, dwell, and decompression phases. Force displacement profiles assess material deformation behavior. Die wall force profiles provide information on friction between materials and the die wall. Compaction profiles provide information on a material's compaction behavior and properties that can be used to optimize the tableting process.
DIffusion, Dissolution and Pharmacokinetic Parameters.pptxKailas Mali
This document discusses various parameters used to study drug release and dissolution from pharmaceutical dosage forms, including diffusion parameters, dissolution parameters, pharmacokinetic parameters, and models like Higuchi and Peppas plots. It defines key terms like diffusion, flux, Fick's first law, and discusses how factors like agitation, pH, surfactants, viscosity, and temperature can influence dissolution. Key drug release mechanisms and models are also summarized.
This document discusses personalized medicine and pharmacogenetics. It defines personalized medicine as providing the right drug to the right patient for the right disease at the right time with the right dosage based on an understanding of the patient's genome. Pharmacogenetics is the study of how genetic variations impact individual responses to drugs by influencing drug metabolism and transport. Examples are provided of genetic polymorphisms that can affect drug acetylation, alcohol metabolism, and response to drugs like clopidogrel, antimalarials, and warfarin. While pharmacogenetics enables more precise treatment, limitations include complex interactions between multiple genes, environment, and other drugs.
1. Dissolution is the process by which a solid substance dissolves in a solvent to form a solution. The rate of dissolution depends on factors like temperature, solvent composition, and the liquid/solid interface area.
2. There are several theories that describe the drug dissolution process, including the diffusion layer model, penetration or surface renewal theory, and interfacial barrier model. The most common model is the diffusion layer model, which involves the formation of a saturated film at the solid/liquid interface and diffusion of the drug through this layer.
3. Key factors that affect drug dissolution include the solubility and permeability of the drug substance, the pH and volume of the dissolution medium, and the design of
This document provides information on pulmonary drug delivery systems and aerosols. It discusses the advantages of pulmonary drug delivery such as localized drug deposition reducing systemic exposure and avoidance of first-pass metabolism. Aerosols are defined as colloidal systems containing liquid/solid particles suspended in a propellant. The document outlines the manufacturing process, components, and quality control tests of aerosols including pressure filling, cold filling, and compressed gas filling apparatuses. Evaluation tests like flash point and flame projection are also mentioned.
The document discusses vaccine delivery systems. It describes the types of vaccines including live attenuated, killed, subunit, conjugate, and DNA vaccines. It discusses various delivery routes for vaccines including mucosal, transdermal, and single shot delivery to provide long-lasting immunity from one dose. Strategies for delivery include vectors, microparticles, and liposomes to protect antigens and induce immune responses. The optimal delivery system depends on the disease and vaccine properties.
1) Vaccine delivery systems aim to improve the immune response to vaccines. Virosomes are a type of delivery system that are biodegradable, biocompatible, and non-toxic. They enable drug delivery into target cells and protect drugs from degradation. However, virosomes have short shelf lives and scaling up poses challenges.
2) Vaccines work by exposing the immune system to antigens from pathogens in a way that stimulates antibody production without causing illness. Antibodies bind to antigens and help the immune system recognize and destroy pathogens. Vaccines contain antigens along with other ingredients like adjuvants to enhance the immune response.
3) There are various types of traditional and innovative vaccines that target different
This document discusses mucosal delivery of vaccines. It begins by introducing mucosal surfaces as the major portal of entry for many pathogens and that immunization through mucosal routes can induce protective immunity at sites of entry. It then discusses various terms related to mucosal tissues and lymphoid structures. The remainder of the document outlines different polymer systems, formulations, design strategies and advantages/limitations for mucosal vaccine delivery, including emulsions, liposomes, polymeric nanoparticles, virosomes and melt-in-mouth strips. It also discusses single shot vaccines that provide protection from multiple diseases with one administration through use of vaccine adjuvants and antigen microencapsulation for delayed release.
This document presents theories of dispersion and mechanisms of emulsion formation. It discusses four traditional theories of dispersion: viscosity theory, film theory, wedge theory, and interfacial tension theory. It also describes limitations of these theories. The document then introduces a modern approach involving droplet formation and stabilization by emulsifying agents. Three mechanisms of emulsion stabilization are described: monomolecular adsorption, multimolecular adsorption, and solid particle adsorption.
This document discusses excipients and their role in drug formulations. It notes that excipients are ingredients other than the active pharmaceutical ingredient that are used to formulate dosage forms. Excipients can act as protective agents, bulking agents, and can improve drug bioavailability. The document then lists common types of excipients and potential interactions between drugs and excipients, such as physical, chemical, biopharmaceutical, and excipient-excipient interactions. It describes several analytical techniques used to detect drug-excipient interactions, including DSC, accelerated stability studies, FT-IR, DRS, chromatography methods, and others.
Self micro-emulsifying drug delivery system (SMEDDS)Himal Barakoti
This document discusses self-microemulsifying drug delivery systems (SMEDDS), including their background, mechanism of action, formulations, stability testing, advantages, and applications. SMEDDS are isotropic mixtures of oils, surfactants, and co-surfactants that form fine oil-in-water emulsions upon mild agitation followed by dilution in gastrointestinal fluids. They can improve the oral absorption of poorly water-soluble drugs and enhance their bioavailability. SMEDDS formulations typically contain an oil, surfactant, co-surfactant, and drug. Their small particle size allows efficient drug release in the GI tract. Stability testing evaluates factors like temperature effects and in vitro drug release. SMEDDS
Mr. Swapnil Kale presented on mucosal delivery of vaccines. He discussed that mucosal delivery allows vaccines to interact with mucosal layers to induce mucosal immunity, preventing pathogens from reaching systemic circulation. Common mucosal routes include sublingual, intranasal, oral, vaginal, and rectal. Mucosal delivery provides advantages like priming primary immunity, enabling mass vaccination through needle-free and non-invasive means. However, challenges include insufficient antigen uptake due to rapid clearance and lack of effective human mucosal adjuvants. Nanotechnology approaches can help overcome these challenges by protecting antigens from degradation and facilitating penetration and sustained release with the use of polymers and adjuvants.
1) Tablet compression involves the application of force to reduce the volume of powder materials through three main processes: compression, compaction, and consolidation. Compression removes air, compaction rearranges particles, and consolidation increases strength through bonding.
2) Key forces involved in compression include inter-particulate and die wall friction, which can be reduced by adding glidants and lubricants, respectively. Distribution forces transmit pressure from the punches to the powder bed and die wall.
3) Compaction profiles examine the relationship between axial and radial pressure. They provide information on elastic versus plastic deformation and ejection forces.
This document discusses the differences between sustained release and controlled release drug formulations and their mechanisms of drug delivery. Sustained release aims to slowly release drug over 8-12 hours, while controlled release delivers drug at a predetermined rate according to bodily needs. Mechanisms include dissolution control using matrix or encapsulation methods, diffusion control using reservoir or matrix devices, and combinations of dissolution and diffusion. Common polymers used for coatings include ethyl cellulose and acrylic resins to control drug release rate.
Immunology - Innate and Acquired ImmunityShigina E S
Title: Innate and Acquired Immunity: Understanding the Two Branches of Our Immune System
Introduction:
The human immune system is a complex network of cells, tissues, and organs that protects us from invading pathogens and foreign substances. In this presentation, we will explore the two branches of the immune system: innate and acquired immunity. We will discuss the key features of each branch, their mechanisms of action, and how they work together to keep us healthy.
Section 1: Innate Immunity
- Innate immunity is the first line of defense against pathogens and foreign substances.
- We will discuss the key features of innate immunity, including physical barriers, such as skin and mucous membranes, and the cellular and molecular components of innate immunity, such as phagocytes and cytokines.
- We will also explore some of the ways in which innate immunity can be activated and how it responds to different types of pathogens.
Section 2: Acquired Immunity
- Acquired immunity, also known as adaptive immunity, is a more specialized and targeted response to specific pathogens or foreign substances.
- We will discuss the key features of acquired immunity, including the role of B and T lymphocytes, antibodies, and memory cells.
- We will also explore some of the ways in which acquired immunity can be activated, including through vaccination, and how it responds to specific antigens.
Section 3: Interaction between Innate and Acquired Immunity
- Innate and acquired immunity work together in a coordinated manner to provide effective protection against pathogens and foreign substances.
- We will discuss how innate immunity can initiate an immune response and activate acquired immunity, and how acquired immunity can enhance the effectiveness of innate immunity.
- We will also explore some examples of how these two branches of the immune system work together in different types of infections.
Conclusion:
Understanding the different branches of our immune system is essential for developing effective strategies to prevent and treat infectious diseases. Innate and acquired immunity work together to provide a coordinated and dynamic defense against pathogens and foreign substances. By exploring the mechanisms and interactions between these two branches of the immune system, we can gain a deeper appreciation for the complexity and power of our immune system.
The document discusses the human immune system. It describes how the innate immune system provides an immediate response to pathogens through physical barriers and cells. If pathogens breach these defenses, the adaptive immune system provides a targeted response through B cells and T cells. The adaptive system also develops immunological memory to mount faster responses. Vaccinations work by exposing the immune system to antigens to develop immunity without causing disease.
The document discusses vaccines and immunization. It provides details on what vaccines are, how they work, different types of vaccines, vaccine production methods, and the risks and benefits of vaccines. It also discusses immunization programs like EPI Pakistan, which aims to vaccinate children against 8 diseases through routine vaccination schedules. The overall goal of vaccines and immunization programs is to safely establish immunity in populations against harmful pathogens.
The document describes the human immune system and its defenses against pathogens. It discusses both nonspecific defenses like physical and chemical barriers provided by the skin, mucus, stomach acids, and inflammatory response, as well as specific defenses like the antibody-mediated and cell-mediated responses involving B cells, T cells, memory cells, and vaccines.
1. Contents: Introduction
History of vaccine
Mechanism of vaccine
Types of vaccines
Uptake of antigens
Single shot vaccines
Mucosal vaccine delivery system
Transdermal vaccine delivery system
Conclusion
References
2. Drug delivery systems describe technologies that carry drugs into or throughout the body. These technologies include the method of delivery, such as a pill that you swallow, syrups or a vaccine that is injected.
3. Vaccines are biological preparation which provide active acquired immunity against particular diseases.
Vaccine word is derived from Latin word “Variolae vaccinea” (cowpox).
It is made of disease causing microbes, which are killed or present in attenuated form or it’s toxins or one of it’s surface proteins.
It stimulates the body immune system against the microbe and destroy it.
The administration of vaccine is called vaccination.
4.Edward Jenner developed 1st vaccine against small pox at 1798 from cowpox.
Louis pasture developed live attenuated cholera vaccine and inactivated anthrax vaccine in 1897 and 1904 respectively.
In 1923, Alexander Glenny introduce a method to inactivate tetanus toxins, this method was used to developed diphtheria vaccine in 1926.
Viral tissue culture method was developed in 1950-1985, which helped in development of inactivated and live attenuated polio vaccines.
5. important terminilogies:-Antibody: A protein found in the blood that is produced in response to foreign substances (e.g. bacteria or viruses) invading the body. Antibodies protect the body from disease by binding to these organisms and destroying them.
Antigens: Foreign substances (e.g. bacteria or viruses) in the body that are capable of causing disease. The presence of antigens in the body triggers an immune response.
Antitoxin: A solution of antibodies against a toxin. Antitoxin can be derived from either human (e.g., tetanus immune globulin) or animal (usually equine) sources (e.g., diphtheria and botulism antitoxin). Antitoxins are used to confer passive immunity and for treatment.
6.Active immunity: The production of antibodies against a specific disease by the immune system. Active immunity can be acquired in two ways, either by contracting the disease or through vaccination. Active immunity is usually permanent, meaning an individual is protected from the disease for the duration of their lives.
Passive immunity: Protection against disease through antibodies produced by another human being or animal. Passive immunity is effective, but protection is generally limited and diminishes over time (usually a few weeks or months).
7.Live attenuated Vaccines
Live attenuated vaccines contain whole bacteria or viruses which have been “weakened”(attenuated) so that they create a protective immune response but do not cause disease in healthy people.
For most modern vaccines this “weakening” is achieved through genetic modification of the pathogens.
E.g. BCG vaccine, MMR vaccine, chickenpox vaccine.
This document provides an overview of vaccine drug delivery systems. It discusses various types of vaccines including traditional vaccines like killed, live attenuated, toxoid, and subunit vaccines as well as innovative conjugate, recombinant vector, and T-cell receptor peptide vaccines. It also describes single shot vaccines, transdermal vaccine delivery using microneedles and jet injectors, as well as mucosal vaccine delivery through intranasal, oral, oral cavity, and intrapulmonary routes. Design strategies for mucosal delivery including emulsion, liposome, polymeric nanoparticles, and virosome-based systems are also summarized.
This document provides an overview of the immune system, including both innate and acquired immunity. It describes how the innate immune system provides immediate protection through physical barriers and internal defenses like phagocytes and inflammation. If pathogens breach these defenses, the acquired immune system activates an antigen-specific response involving B and T cells that results in immunological memory. The differences between the innate and acquired systems are highlighted. Specific components of both systems like phagocytosis, inflammation, antibodies, and active/passive immunity are also explained in detail.
This document provides an overview of the immune system, including both innate and acquired immunity. The innate immune system provides immediate response through physical barriers like skin and mucus as well as internal defenses like phagocytes and inflammation. If pathogens breach these defenses, the acquired immune system activates an antigen-specific response using B and T cells. The document also discusses active and passive immunity, humoral versus cell-mediated immunity, and how vaccines work to stimulate immune response.
This document summarizes immune systems, including innate and acquired immunity. The innate immune system provides immediate protection through physical barriers and internal defenses like phagocytosis and inflammation. If pathogens breach these defenses, the acquired immune system activates lymphocytes to develop pathogen-specific immunity through humoral and cell-mediated responses. Vaccinations expose the immune system to antigens to develop active or passive immunity and memory cells to mount faster responses upon future exposure.
The document discusses immunization and the immune system. It begins by thanking teachers for providing an opportunity to study immunization. It then provides 3 paragraphs summarizing key aspects of immunization: it stimulates the body's immune system to protect against infection through vaccination; it provides long-lasting immunity through immune system memory; and it harnesses this memory to provide quicker protection if the pathogen is encountered again. The document emphasizes that immunization is a safe and effective way to protect individuals and communities from serious diseases.
This document summarizes the immune system, including both innate and acquired immunity. It discusses the barriers that prevent pathogen entry and the components of the innate system that provide an immediate response, like phagocytes. The acquired system mounts a pathogen-specific response through B and T cells. It also covers the differences between these systems and gives examples of vaccination methods that stimulate immune memory.
This document summarizes key concepts about the immune system. It describes the innate immune system as the first line of defense, including physical barriers and internal defenses like phagocytosis and inflammation. The acquired immune system is activated if pathogens evade the innate response, and develops pathogen-specific immunity using lymphocytes and antibodies. Immunity can be active, acquired from exposure, or passive, acquired from transfer of antibodies. The summary provides an overview of the main components and functions of the immune system.
This document summarizes key concepts about the immune system. It describes the innate immune system as the first line of defense, including physical barriers and internal defenses like phagocytosis and inflammation. The acquired immune system is activated if pathogens evade the innate response, and results in pathogen-specific immunity and immunological memory. Major cells involved are B and T lymphocytes. Vaccinations work to induce an immune response without causing disease.
This document provides an overview of the immune system, including both innate and acquired immunity. It discusses the physical and internal barriers that make up the innate immune system and help fight off pathogens. The innate system provides an immediate response including phagocytosis and inflammation. The acquired immune system activates slower but produces a pathogen-specific response through B and T cells. It provides both active and passive immunity and involves humoral and cell-mediated responses. The document also covers vaccinations which stimulate immunity through various methods like inactivated, attenuated, subunit, and virus-like particle vaccines.
Vaccines work by exposing the immune system to antigens from viruses or bacteria. This triggers an immune response that produces antibodies to fight future infections from these pathogens. Vaccines contain weakened or killed forms of viruses or bacteria, along with preservatives and adjuvants. When administered, they mimic natural infections and induce immunity. Traditional vaccines include live-attenuated, inactivated, toxoid and subunit vaccines. Innovative vaccines include conjugate vaccines, which link weak antigens to strong carriers, and recombinant vector vaccines. Quality control ensures vaccines are safe, potent and effective through in-process and final product testing.
The document provides an overview of the immune system, including both innate and acquired immunity. It discusses how the innate immune system provides immediate protection through physical barriers and internal defenses like phagocytosis and inflammation. If pathogens breach these defenses, the acquired immune system activates through lymphocytes to develop pathogen-specific immunity either actively through exposure or vaccination, or passively from mother to child. The acquired response results in immunological memory and faster response upon reexposure.
The immune system protects the body from infection through a complex network of interacting cells and molecules. It includes both non-specific defenses that provide immediate protection, and specific adaptive defenses that develop over time through vaccination or exposure to pathogens. The adaptive immune system includes B cells that produce antibodies, T cells that coordinate immune responses, and phagocytes that engulf foreign substances. Vaccination exposes the immune system to an antigen in a controlled way to stimulate lifelong immunity against disease.
The interaction between infectious agents and the immune system.pptxAmirRaziq1
The document discusses the human immune system and how it protects the body from infection. It describes the three lines of defense: physical barriers, the innate immune system including macrophages and natural killer cells, and the adaptive immune system including B cells that produce antibodies and T cells that destroy infected cells. It also discusses the differences between active and passive immunity as well as how vaccines work to stimulate active immunity without causing illness.
The immune system protects the body from pathogens through nonspecific and specific defenses. Nonspecific defenses provide a first line of defense against pathogens and include physical barriers like skin as well as chemical barriers and inflammation. If pathogens breach these defenses, the specific immune response is triggered. This involves B cells and antibodies that provide humoral immunity against pathogens in bodily fluids, and T cells that provide cell-mediated immunity against intracellular pathogens and abnormal cells. Memory B and T cells provide long-term immunity against previously encountered pathogens. Vaccines stimulate active immunity by exposing the immune system to antigens in a controlled way. Passive immunity can also be provided temporarily via transfer of antibodies from other sources.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
2. CONTENT
Introduction of vaccine
How vaccine works ?
Types of vaccine
Single shot vaccine
Uptake of Antigen
Transdermal delivery of vaccine
2
3. WHAT ARE VACCINES...?
A vaccine is a biological preparation that improves immunity to
a particular disease.
A vaccine typically contains an agent that resembles a disease-
causing microorganism, and is often made from weakened or
killed forms of the microbe, its toxins or one of its surface
proteins.
The agent stimulates the body's immune system to recognize
the agent as foreign, destroy it, and "remember" it, so that the
immune system can more easily recognize and destroy any of
these microorganisms that it later encounters.
Vaccines can be prophylactic ( to prevent or ameliorate the
effects of a future infection by any natural or wild pathogen), or
therapeutic ( vaccines against cancer).
3
4. THE IMMUNE SYSTEM— THE BODY’S
DEFENSE AGAINST INFECTION
To understand how vaccines work, it is helpful to first look at
how the body fights illness.
When germs, such as bacteria or viruses, invade the body, they
attack and multiply.
This invasion is called an infection, and the infection is what
causes illness.
The immune system uses several tools to fight infection.
Blood contains red blood cells, for carrying oxygen to tissues
and organs, and white or immune cells, for fighting infection.
These white cells consist primarily of B-lymphocytes, T-
lymphocytes, and macrophages:
4
5. 1.Macrophages (big eaters):
Macrophages are white blood cells that swallow up and digest
germs, plus dead or dying cells. The macrophages leave behind
parts of the invading germs called antigens. The body identifies
antigens as dangerous and stimulates the body to attack them.
2. Antibodies :
Antibodies attack the antigens left behind by the macrophages.
Antibodies are produced by defensive white blood cells called B-
lymphocytes.
3. T-lymphocytes :
T-lymphocytes are another type of defensive white blood cell.
They attack cells in the body that have already been infected
5
6. The first time the body encounters a
germ, it can take several days to
make and use all the germ-fighting
tools needed to get over the
infection.
After the infection, the immune
system remembers what it learned
about how to protect the body
against that disease.
The body keeps a few T-
lymphocytes, called memory cells
that go into action quickly if the
body encounters the same germ
again.
When the familiar antigens are
detected, B-lymphocytes produce
antibodies to attack them.
6
7. HOW VACCINE WORK
Antigens
Sound
the
Alarm
The molecules on a microbe that identify as
foreign agent and stimulate the immune
system to attack it are called “antigens.” Every
microbe carries its own unique set of antigens,
which are central to creating vaccines.
Macrophages digest most parts of the
microbes but save the antigens and carry them
back to the lymph nodes ,where immune
system cells congregate.
In these nodes, macrophages sound the alarm
by “regurgitating” the antigens, displaying them
on their surfaces so other cells, such as
specialized defensive white blood cells called
lymphocytes, can recognize them.
7
8. 2. Lymphocytes Take Over
• There are two major kinds of lymphocytes, T cells and B cells, and
they do their own jobs in fighting off infection.
• T cells function either offensively or defensively.
• The offensive T cells don’t attack the microbe directly, but they use
chemical weapons to eliminate the human cells that have already
been infected. these, cytotoxic T cells also called killer T cells.
• The defensive T cells, also called helper T cells, defend the body
by secreting chemical signals that direct the activity of other
immune system cells.
• Helper T cells assist in activating killer T cells, and helper T cells
also stimulate and work closely with B cells (antibodies).
• The work done by T cells is called the cellular or cell-mediated
immune response.
8
9. B cells make and
secrete extremely
important
molecular
weapons called
antibodies.
Antibodies usually
work by first
grabbing onto the
microbe’s antigen,
and then sticking
to and coating the
microbe.
Antibodies and
antigens fit
together like
pieces of a jigsaw
puzzle—if their
shapes are
compatible, they
bind to each other.
Each antibody can
usually fit with only
one antigen.
9
10. 3. Antibodies in Action
The antibodies circulate throughout the human body and attack the
microbes that have lurking in the blood or the spaces between cells.
When antibodies gather on the surface of a microbe, it becomes unable to
function.
Antibodies signal macrophages and other defensive cells to come eat the
microbe. Antibodies also work with other defensive molecules that
circulate in the blood, called complement proteins, to destroy microbes.
The work of B cells is called the humoral immune response, or simply the
antibody response. The goal of most vaccines is to stimulate this response.
In fact, many infectious microbes can be defeated by antibodies alone,
without any help from killer T cells.
10
11. 4. Clearing the Infection: Memory Cells and Natural Immunity
When T cells and antibodies begin to eliminate the microbe faster
than it can reproduce, the immune system finally has the upper hand.
Gradually, the virus or infection disappears from the body.
After the body eliminates the disease, some microbe-fighting with B
cells and T cells are converted into memory cells.
Memory B cells can quickly divide into plasma cells and make more
antibody if needed.
Memory T cells can divide and grow into a microbe-fighting army.
If re-exposure to the infectious microbe occurs, the immune system
will quickly recognize how to stop the infection.
11
12. HOW VACCINES MIMIC INFECTION
Vaccines teach the immune system by mimicking a natural infection.
For example, the yellow fever vaccine, first widely used in 1938, contains a
weakened form of the virus that doesn’t cause disease or reproduce very well.
Human macrophages can’t tell that the vaccine viruses are weakened, so they
engulf the viruses as if they were dangerous.
In the lymph nodes, the macrophages present yellow fever antigen to T cells
and B cells.
A response from yellow-fever-specific T cells is activated.
B cells secrete yellow fever antibodies.
The weakened viruses in the vaccine are quickly eliminated. The mock
infection is cleared, and humans are left with a supply of memory T and B cells
for future protection against yellow fever.
12
13. TYPES OF VACCINE
1.Live Attenuated Vaccines:
These vaccines are made up of living virus or bacteria that
have been weakened (attenuated) by scientists.
These vaccines are very effective, but in rare cases (such
as in people with compromised immune systems), can
cause infection.
Rotavirus, chickenpox, and measles, mumps and rubella
vaccines are live attenuated vaccines. The BCG vaccine is
also a live attenuated vaccine
13
14. 2.Inactivated Vaccines:
More stable than live vaccines, these vaccines contain disease microbes
that have been killed with chemicals.
Inactivated vaccines tend to stimulate a weaker immune response than live
vaccines, and may require booster shots to maintain immunity.
Hepatitis A, influenza and polio vaccines are inactivated vaccines
3. Toxoid vaccines:
These vaccines are used when a bacterial toxin is the main cause of illness.
Scientists have found that they can inactivate toxins by treating them with
formalin, a solution of formaldehyde and sterilized water. Such “detoxified”
toxins, called toxoids, are safe for use in vaccines.
Vaccines against diphtheria and tetanus are examples of toxoid vaccines.
14
15. 4. Conjugate Vaccines:
Some bacteria have special coatings that hide them from the immune system.
Conjugate vaccines link these coatings to an organism that an immature
immune system can recognize, so it can respond and produce immunity.
The vaccine that protects against Haemophilus influenzae type B (Hib)
is a conjugate vaccine.
5. Subunit Vaccines:
These vaccines are made with only the parts of the microbe that stimulate the
immune system.
Subunit vaccines can be made by taking apart the actual microbe, or they can
be made in the laboratory using genetic engineering techniques.
Since these vaccines contain only parts of the microbe rather than the whole
microbe, the chance of temporary reactions is even lower than with other
kinds of vaccines.
Hepatitis B virus is an example of subunit vaccine.
15
16. GENERAL METHOD FOR VACCINE
PRODUCTION
16
Selecting strain for vaccine production
Growing the microorganism
Isolation and purification of
microorganism
Inactivation of organism
Formulation of vaccine
Upper stream
process
Down
stream
process
17. SINGLE DOSE VACCINE
Single dose vaccines are given at a
single contact point for preventing 4
to 6 disease.
In order to increase the therapeutic
efficiency of such vaccines,
adjuvants are used .
17
18. VACCINE ADJUVANTS
An adjuvant is an ingredient of a vaccine that helps create a
stronger immune response in the patient’s body. In other words,
adjuvants help vaccines work better.
Some vaccines made from weakened or dead germs contain
naturally occurring adjuvants and help the body produce a strong
protective immune response.
However, most vaccines developed today include just small
components of germs, such as their proteins, rather than the
entire virus or bacteria.
These vaccines often must be made with adjuvants to ensure the
body produces an immune response strong enough to protect the
patient from the germ he or she is being vaccinated against.
18
20. TYPES OF ADJUVANTS
Gel types
eg : aluminum hydroxide and phosphate, calcium phosphate .
Oil emulsion and emulsifier based
Particulate based
eg : liposomes , biodegradable microspheres.
synthetic
20
21. BIODEGRADABLE POLYMERS
Biodegradable polymers Defined as polymers comprised of monomers
linked to one another through functional groups and have unstable links in
the backbone.
Broken down into biologically acceptable molecules that are metabolized
and removed from the body via normal metabolic pathways
Types of biodegradable polymers:
Types of biodegradable polymers There are two types of biodegradable
polymers.
1.Natural biodegradable polymers
eg : Albumin, Collagen, Gelatin etc.,
2.Synthetic biodegradable polymers
eg : Aliphatic poly(esters), Polyanhydride , Polyphosphazene ,
poly aminoacid , Poly( orthoesters )etc.,
21
22. BIODEGRADABLE POLYMERS
AS ADJUVANTS
Biodegradable polymers such as poly( lactide -co-glycolic acids) is most
commonly used for vaccine delivery.
This polymers is mainly required for
controlled release of the drug from polymer matrix.
Targeting to appropriate cell types to generate optimum response.
Development of formulation that can be used as non-invasive.
22
23. OBJECTIVES
To elicit a protective immune response for a long duration from a
single-contact immunization.
Potentiate the immune response to the vaccine without manifesting
any adverse effect.
Incorporate many vaccine in a single formulation.
23
24. TRANSDERMAL DELIVERY OF
VACCINE
Transdermal delivery of vaccine is simple, painless and economical
approach to vaccination.
Transdermal delivery of vaccine is a novel immunization strategy by which
antigen and adjuvants are applied topically to intact skin to induce potent
antibody and cell mediated response.
Proteineous antigen alone or in combination with conventional bioactive
carriers could not penetrate through the intact skin.
24
25. ADVANTAGES
Prevent unnecessary invasion to body.
Prevents or bypasses the problem related to degradation of peptidal
vaccine as in case of oral route.
It drains the antigens or carrier associated antigens to the
lymphatic system and hence to the lymph nodes.
It prevents unnecessary toxicity encountered in case of immunization by
other routes.
25
26. SKIN AS A TARGET SITE FOR
DELIVERY
Various routes within the skin are exploited for the delivery/ta
rgeting of antigen to the specialized cells.
These include follicular pathway, normal pores present in the sk
in,
lamellar lipid bodies and through corneocytes.
The skin is exploited as a route for immunization, i.e. topical
immunization because it shows specific (immunity) as well no
nspecific (inflammation) responses for foreign substances.
26
27. These responses are a result of presence of
immunocompetent cells within the skin, which include
Langerhan's cells (LC),
Dendritic epidermal T-cells
epidermotropic lymphocytes.
The mast cells also represent the immunocompetent cells of
dermis.
Other cells present in the skin are resident antigen presenting ce
lls and transient inflammatory lymphoid cells (e.g., polymorp
honucleocytes, monocytes and lymphocytes).
27
28. Skin consists of SALT (skin associated lymphoid tissue) responsible for th
e specific and nonspecific responses.
The SALT composed of the epidermal antigen presenting cells (APC) and
migratory T- lymphocytes in circulation, which have avidity for epidermal
tissues.
The existence of SALT in the skin is supported by the cytokinin's,
which have capacity to regulate the immune responses.
The antigens that come in contact with the epidermis and hence in co
ntact with the antigen presenting cells are taken to the lymph nodes by me
ans of the lymphatics, because migratory T‐cells are attracted towards the
peripheral lymph nodes.
After binding to high endothelial venules (HEV) they enter into the lymphno
des. The accumulation of T-lymphocytes gives rise to immunological
response.
28
30. APPROACHES
Physical
approach
Electroporation
can be used for
the transfer of
bioactive
molecules across
stratum corneum.
Electroporation is used
for the delivery gene to
the keratinocytes for
the immunization as
well as for thr gene
therapy without
compromising the
viability of cell.
30
31. 2. Chemical approach:
The majority of protocols to increase the permeability of the
epidermis (stratum corneum ) include utilization of the chemical
such as ; surfactant, alcohol and polyols.
• They increase the permeability by following mechanism;
• Increasing the fluidity of skin lipids.
• Hydrating the polar pathway.
• Opening the heterogeneous multiaminate pathways.
• Keratolytic action.
Disadvantages: the chronic use of these chemicals for the
permeability enhancement may have dangerous side
effects.
31
32. 3. Vesicular approach
This approach is gaining wide acceptance nowadays.
It include utilization of vesicles, virosomes and reconstituted
viral envelop since they are efficient in transfer of immunogens
across the skin.
These carrier target either through keratinocytes or through
follicles.
The vesicles that enhance skin permeability of bioactive inc
lude;
liposomes, niosomes, transfersomes, reconstituted sendai virus
envelop (RSVE), adenovirus vector, herpes simplex virus (HSV) a
nd amplicon vector.
32
33. a.Liposomes:
It have been studied extensively transdermal delivery.
It promote antigenic response of various bacterial, viral and
tumor cell antigen.
This inherent immunoadjuvant action of liposome depends on
their structural characteristic, which control their fate in the
body.
b. Niosomes:
nonionic surfactant based vesicles that can be utilized as a topic
al carrier for immunogens (Antigens or DNA) for trans
dermal delivery.
Niosomes of decycloethyleneoleylether are found to fuse with th
e corneocytes.
This fusion to corneocytes and formation of lipid stocks indicate
that niosomes are most promising vesicular carriers for transder
mal delivery of lipophilic molecules.
33
34. c. Transferosomes:
Transferosomes are specially designed lipid surfactant vesicles f
or transdermal of bioactive molecules.
They are ultradeformable carrier system having high capacity of
changing their shape and passing through the natural pores i
n the stratum corneum.
They are highly efficacious in transferring the bioactive
molecules across the stratum corneum.
They can pass through the small pores present in the skin
having diameter five times less than their own diameter.
34
35. d. Viral vectors:
Viral vector is another class of topical vaccine carriers.
They can be utilized for epidermal transfer of the DNA or other su
itable antigen.
These include adenovirus vector and HSV amplican vector.
Reconstituted viral vectors or virosomes have also been utilized
for intracellular targeting of encapsulated DNA/antigen.
The reconstituted sendai virus envelops (RSVE) can be applied t
opically for efficient gene or antigen transfer.
35
37. SONOPHORESIS
uses ultrasound to permeabilize the stratum corneum layer of the skin.
ultrasound travels through a coupling fluid, it produces cavitation
bubbles. These bubbles oscillate and increase in size over many cycles
of the pressure wave.
The main mechanism for sonophoresis-enhanced permeability of the
skin is particular inertial cavitation, whereby cavitation bubbles can
implode when they are close to a liquid–solid interface, generating an
intense local shockwave.
This produces a jet of liquid that can penetrate the stratum corneum.
And, because the cavitation effect inversely correlates with ultrasound
frequency, this technique is efficient for permeabilization of the skin.
for administration of tetanus toxoid in mice and hepatitis B surface
antigen in pigs
37
38. 38
The SonoPrep® ultrasound device
Disadvantage
technique may cause
burning of the skin in
some cases, and
epidermal necrolysis
may occur at high
intensities.
39. MICRONEEDLE-ASSISTED
DELIVERY
microneedles (MN) are needles with lengths in the micrometer range
(typically less than 1000 micrometers) which create pores in the skin
and enable medications or vaccines to be delivered locally or
transdermally into systemic circulation.
MNs can be categorized as hollow, solid, coated, dissolving, or
hydrogel-forming.
It has has been applied to DNA vaccines to help resolve the problem of
their poor immunogenicity.
It has been used to administer polio vaccine to volunteers. It has also
been used to investigate delivery of the bacillus Calmette-Guérin
(BCG) vaccine and the tetanus toxoid in animal models.
However, it can be challenging to deliver high doses of medications
using MNs.
39
41. 41
Dissolvable MNs
for rapid or
controlled
release of the
drug
incorporated
within the
microneedles
Hollow MNs used
to puncture the
skin and enable
release of a liquid
drug following
active infusion or
diffusion of the
formulation
through the
needle bores.
42. The first two commercially marketed MN-
based products are Intanza® and
Micronjet®
1.Intanza is the first influenza vaccine that
targets the dermis, a highly immunogenic
area.
It was developed and licensed by Sanofi
Pasteur MSD Limited and is being marketed
in two strengths; Intanza® 9 µg for adults
aged between 18 and 59 years
Intanza® influenza vaccine system has a
needle length of 1.5 mm.
2. MicronJet is a single use, MN-based
device for intradermal delivery
of vaccines and drugs. It was developed and
licensed by NanoPass. ®15 µg for adults of
60 years and above.
42
43. IONTOPHORESIS
Iontophoresis involves application of a small electric
current to permeabilize the skin.
It is a non-invasive and efficient technology for
transdermal vaccine delivery, and is particularly helpful
because, when using transdermal vaccine delivery, it can be
challenging to accumulate enough antigen in the epidermis
for effective exposure to the skin’s DCs.
In various animal studies, this technique has been shown to
effectively deliver and generate an immune response to
tumor antigens and hepatitis B vaccines.
43
44. Phoresor, Lidosite, E-trans are examples of three
commercially developed iontophoretic delivery
system.
The first approved commercial iontophoretic patch
system was LidoSite®, which was developed to
deliver lidocaine for fast dermal anesthesia.
44
LIMITATION:
Iontophoresis has a minor effect on
skin structure over short treatment
periods due to the low-voltage
nature of the applied electric
current, when compared to
electroporation.